GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Novo Integrated Sciences Inc (NAS:NVOS) » Definitions » Piotroski F-Score

Novo Integrated Sciences (Novo Integrated Sciences) Piotroski F-Score : 3 (As of May. 01, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Novo Integrated Sciences Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Novo Integrated Sciences has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Novo Integrated Sciences's Piotroski F-Score or its related term are showing as below:

NVOS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 5
Current: 3

During the past 13 years, the highest Piotroski F-Score of Novo Integrated Sciences was 5. The lowest was 2. And the median was 3.


Novo Integrated Sciences Piotroski F-Score Historical Data

The historical data trend for Novo Integrated Sciences's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Integrated Sciences Piotroski F-Score Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 4.00 2.00 5.00

Novo Integrated Sciences Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 5.00 5.00 3.00

Competitive Comparison of Novo Integrated Sciences's Piotroski F-Score

For the Medical Care Facilities subindustry, Novo Integrated Sciences's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Integrated Sciences's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Novo Integrated Sciences's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb24) TTM:Last Year (Feb23) TTM:
Net Income was -1.497 + -3.16 + -4.68 + -2.746 = $-12.08 Mil.
Cash Flow from Operations was -0.858 + -0.229 + -2.152 + -1.714 = $-4.95 Mil.
Revenue was 3.293 + 3.303 + 3.891 + 3.171 = $13.66 Mil.
Gross Profit was 1.314 + 0.928 + 1.944 + 1.324 = $5.51 Mil.
Average Total Assets from the begining of this year (Feb23)
to the end of this year (Feb24) was
(36.489 + 35.745 + 35.563 + 37.244 + 34.949) / 5 = $35.998 Mil.
Total Assets at the begining of this year (Feb23) was $36.49 Mil.
Long-Term Debt & Capital Lease Obligation was $1.70 Mil.
Total Current Assets was $5.02 Mil.
Total Current Liabilities was $9.96 Mil.
Net Income was -3.81 + -22.427 + -3.935 + -4.621 = $-34.79 Mil.

Revenue was 13.852 + -8.145 + 3.419 + 2.557 = $11.68 Mil.
Gross Profit was 2.409 + -0.092 + 1.74 + 0.971 = $5.03 Mil.
Average Total Assets from the begining of last year (Feb22)
to the end of last year (Feb23) was
(70.32 + 71.793 + 40.873 + 37.749 + 36.489) / 5 = $51.4448 Mil.
Total Assets at the begining of last year (Feb22) was $70.32 Mil.
Long-Term Debt & Capital Lease Obligation was $1.96 Mil.
Total Current Assets was $4.05 Mil.
Total Current Liabilities was $6.18 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Novo Integrated Sciences's current Net Income (TTM) was -12.08. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Novo Integrated Sciences's current Cash Flow from Operations (TTM) was -4.95. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Feb23)
=-12.083/36.489
=-0.33114089

ROA (Last Year)=Net Income/Total Assets (Feb22)
=-34.793/70.32
=-0.494781

Novo Integrated Sciences's return on assets of this year was -0.33114089. Novo Integrated Sciences's return on assets of last year was -0.494781. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Novo Integrated Sciences's current Net Income (TTM) was -12.08. Novo Integrated Sciences's current Cash Flow from Operations (TTM) was -4.95. ==> -4.95 > -12.08 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Feb24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb23 to Feb24
=1.703/35.998
=0.04730818

Gearing (Last Year: Feb23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb22 to Feb23
=1.956/51.4448
=0.03802134

Novo Integrated Sciences's gearing of this year was 0.04730818. Novo Integrated Sciences's gearing of last year was 0.03802134. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Feb24)=Total Current Assets/Total Current Liabilities
=5.019/9.959
=0.50396626

Current Ratio (Last Year: Feb23)=Total Current Assets/Total Current Liabilities
=4.051/6.178
=0.65571382

Novo Integrated Sciences's current ratio of this year was 0.50396626. Novo Integrated Sciences's current ratio of last year was 0.65571382. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Novo Integrated Sciences's number of shares in issue this year was 17.643. Novo Integrated Sciences's number of shares in issue last year was 7.933. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=5.51/13.658
=0.40342656

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5.028/11.683
=0.43036891

Novo Integrated Sciences's gross margin of this year was 0.40342656. Novo Integrated Sciences's gross margin of last year was 0.43036891. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Feb23)
=13.658/36.489
=0.37430458

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Feb22)
=11.683/70.32
=0.1661405

Novo Integrated Sciences's asset turnover of this year was 0.37430458. Novo Integrated Sciences's asset turnover of last year was 0.1661405. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Novo Integrated Sciences has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Novo Integrated Sciences  (NAS:NVOS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Novo Integrated Sciences Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Novo Integrated Sciences's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Integrated Sciences (Novo Integrated Sciences) Business Description

Traded in Other Exchanges
N/A
Address
11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Executives
Sarfaraz Ali director C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Robert Letterio Oliva director 115 BELFIELD RD, TORONTO A6 L0J 1C0
Sterling M. Jimenez officer: Principal Financial Officer C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Michael Ross Pope director 1045 PROGRESS CIRCLE, LAWRENCEVILLE, GEORGIA GA 30043
Alex Flesias director 41 LANDMARK COURT, UNIONVILLE A6 L3R 9N7
Michael Joseph Gaynor director 49 BALMORAL ST, KEMPTVILLE A6 K0G 1J0
Robert Mattacchione director, 10 percent owner, officer: Chief Executive Officer 79 SELVAPIANO CRES, WOODBRIDGE A6 L4H 0X1
Pierre Joseph Dalcourt director, 10 percent owner 35 BRYANT ST , BOX 2230, HEARST A6 P0L 1N0
Christopher Mehlin David director, officer: President 10425 SE 22ND ST., BELLEVUE WA 98004
Thomas Edward Bray officer: Principal Financial Officer C/O NOVO INTEGRATED SCIENCES, INC., 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Rebecca Aw Mcdonald officer: Chief Accounting Officer 1301 INTERNATIONAL SPEEDWAY BLVD., DELAND FL 32724
James Jr Teters director 1200 FLIGHTLINE BLVD, STE 5, DELAN FL 32724
Phyllis Rouse officer: secretary 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Jay Hilden officer: President & CEO 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Robert Adamo director 1200 FLIGHTLINE BOULEVARD, SUITE 5, DELAND FL 32724

Novo Integrated Sciences (Novo Integrated Sciences) Headlines

From GuruFocus